Search Here

Nestle SA is all set for a biotechnological partnership with Cellular Dynamics International (CDI), according to a report from Wall Street Journal.

The partnership will let Nestle study the relation between diets and diseases.

“Under the deal, Nestlé will obtain brain and liver cells from Cellular Dynamics International Inc. and study how nutrients found in foods affect these human cells, according to Emmanuel Baetge, director of the Nestlé Institute of Health Sciences, a research arm of the Swiss company. Nestlé aims to use the insights to develop nutritionally enhanced drinks, smoothies and other products that it can market as having medical benefits,” wrote WSJ in the report.

Madison, Wisconsin-based Cellular Dynamics has top pharmaceutical players as its customer but it is the first time when it has linked with a food company.

Through proper research Nestle will be eyeing an opportunity to rule down all those bogus health claims that have given regulators act against the company.

According to market-research company Euromonitor International, the world-wide market for health and wellness food beverages is expected to grow $944 billion by 2018 in contrast to $772 billion pervious year.

Expectations are that both company will announce the deal later this week, without disclosing any financial terms.